Central nervous system PET-CT imaging reveals regional impairments in pediatric patients with Wolfram syndrome

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Zmyslowska, Agnieszka ^a   Malkowski, Bogdan ^b   Fendler, Wojciech ^a   Borowiec, Maciej ^a   Antosik, Karolina ^a   Gnys, Piotr ^a   Baranska, Dobromila ^c   Mlynarski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

^c University Children's Hospital No4   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM; CHILD; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; NEUROANATOMY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; SCHOOL CHILD; SYMPTOMATOLOGY; TEMPORAL LOBE; WFS1 GENE; WOLFRAM SYNDROME; BRAIN; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; MALE; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; SCINTISCANNING;

ADOLESCENT; BRAIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; WOLFRAM SYNDROME;

EID: 84919905103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115605     Document Type: Article

References (30)

1. Yamada T, Ishihara H, Tamura A, Takahashi R, Yamaguchi S, et al. (2006) WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet 15: 1600-1609.
2. Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, et al. (2010) Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 20: 744-755.
3. Barrett TG, Bundey SE, Macleod AF (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346: 1458-1463.
4. Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, et al. (2011) Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol 69: 501-508.
5. Barrett TG, Bundey SE (1997) Wolfram (DIDMOAD) syndrome. J Med Genet 34: 838-841.
6. D'Annunzio G, Minuto N, D'Amato E, De Toni T, Lombardo F, et al. (2008) Wolfram Syndrome (Diabetes Insipidus, Diabetes, Optic Atrophy, and Deafness). Clinical and genetic study. Diabetes Care 31: 1743-1745.
7. Kinsley BT, Swift M, Dumont RH, Swift RG (1995) Morbidity and mortality in the Wolfram syndrome. Diabetes Care. 18: 1566-1570.
8. Ito S, Sakakibara R, Hattori T (2007) Wolfram syndrome presenting marked brain MR imaging abnormalities with few neurologic abnormalities. Am J Neuroradiol 28: 305-306.
9. Yang MS, Chen CC, Cheng YY, Tyan YS, Wang YF, et al. (2005) Imaging characteristics of familial Wolfram syndrome. J Formos Med Assoc 104: 129-132.
10. Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C (1999) MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 41: 729-731.
11. Shannon P, Becker L, Deck J (1999) Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol 98: 304-308.
12. Hadidy AM, Jarrah NS, Al-Till MI, El-Shanti HE, Ajlouni KM (2004) Radiological findings in Wolfram syndrome. Saudi Med J 25: 638-641.
13. Leiva-Santana C, Carro-Martinez A, Monge-Argiles A, Palao-Sanchez A (1993) Neurologic manifestations in Wolfram's syndrome. Rev Neurol (Paris) 149: 26-29.
14. Imabayashi E, Matsuda H, Tabira T, Arima K, Araki N, et al. (2013) Comparison between brain CTand MRI for voxel-based morphometry of Alzheimer's disease. Brain Behav. 3: 487-93.
15. Yamane T, Ikari Y, Nishio T, Ishii K, Ishii K, et al. (2013) Visual-statistical interpretation of 18F-FDGPET images for characteristic Alzheimer patterns in a multicenter study: Inter-rater concordance and relationship to automated quantitative evaluation. AJNR Am J Neuroradiol. [Epub ahead of print]
16. Zmyslowska A, Borowiec M, Antosik K, Szalecki M, Stefanski A, et al. (2011) Wolfram syndrome in the Polish population: novel mutations and genotype-phenotype correlation. Clin Endocrinol (Oxf). 75: 636-641.
17. Rando TA, Horton JC, Layzer RB (1992) Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology. 42: 1220-1224.
18. Marshall BA, Permutt MA, Paciorkowski AR, Hoekel J, Karzon R, et al. (2013) Phenotypic characteristics of early Wolfram syndrome. Orphanet J Rare Dis. 8: 64-75.
19. London K, Howman-Giles R (2014) Normal cerebral FDG uptake during childhood. Eur J Nucl Med Mol Imaging 41: 723-735.
20. Shan ZY, Leiker AJ, Onar-Thomas A, Li Y, Feng T, et al. (2014) Cerebral glucose metabolism on positron emission tomography of children. Hum Brain Mapp35: 2297-2309.
21. Pakdemirli E, Karabulut N, Bir LS, Sermez Y (2005) Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol 49: 189-191.
22. Mathis S, Paquis V, Mesnage V, Balaboï I, Gil R, et al. (2007) Wolfram's syndrome presenting as a cerebellar ataxia. Rev Neurol (Paris) 163: 197-204.
23. Waschbisch A, Volbers B, Struffert T, Hoyer J, Schwab S, et al. (2011) Primary diagnosis of Wolfram syndrome in an adult patient-case report and description of a novel pathogenic mutation. J Neurol Sci 300: 191-193.
24. Genís D, Dávalos A, Molins A, Ferrer I (1997) Wolfram syndrome: a neuropathological study. Acta Neuropathol 93: 426-429.
25. Hilson JB, Merchart SN, Adams JC, Joseph JT (2009) Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol 118: 415-428.
26. Hershey T, Lugar HM, Shimony JS, Rutlin J, Koller JM, et al. (2012) Early brain vulnerability in Wolfram syndrome. PLoS One 7: e40604.
27. Dunn JT, Cranston I, Marsden PK, Amiel SA, Reed LJ (2007) Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in Type 1 diabetes. A new player in hypoglycemia unawareness? Diabetes 56: 2766-2773.
28. 18F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50: 2329-2336.
29. Bingham EM, Dunn JT, Smith D, Sutcliffe-Goulden J, Reed LJ, et al. (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia 48: 2080-2089.
30. Zmyslowska A, Borowiec M, Fichna P, Iwaniszewska B, Majkowska L, et al. (2014) Delayed recognition of Wolfram syndrome frequently misdiagnosed as type 1 diabetes with early chronic complications. Exp Clin Endocrinol Diabetes 122: 35-38.